Search for: "C & D TECHNOLOGIES, INC."
Results 21 - 40
of 1,461
Sort by Relevance
|
Sort by Date
29 Feb 2024, 7:15 pm
Hatcher, Injustice, Inc. [read post]
29 Feb 2024, 3:48 pm
In SEKRI, Inc. v. [read post]
29 Feb 2024, 3:23 pm
C 12-0195 PJH, 2012 WL 12964819, at *3 (N.D. [read post]
26 Feb 2024, 2:48 pm
Chevron, U.S.A., Inc. v. [read post]
26 Feb 2024, 9:19 am
EcoFactor, Inc. is the holder of U.S. [read post]
15 Feb 2024, 8:00 am
Candace C. [read post]
13 Feb 2024, 3:50 am
Chevron U.S.A., Inc. v. [read post]
2 Feb 2024, 1:39 pm
See, e.g., Wayne C. [read post]
19 Jan 2024, 10:59 am
Examples of G&A expenses include costs incurred for senior management, accounting, finance, human resources, information technology, business development, sales, and marketing. [read post]
12 Jan 2024, 3:35 am
[Section 2(d) refusal of BOSSCOIN for, inter alia, various cryptocurrency-related services, in view of the registered mark BOSCOIN for various virtual currency-related services.]In re Master Brands, Serial No. 88892357 (January 9, 2024) [not precedential] (Opinion by Judge Cynthia C. [read post]
11 Jan 2024, 12:59 pm
Genentech, Inc., 81 F.4th 1362 (Fed. [read post]
8 Jan 2024, 8:11 pm
In Appeal of First Solar, Inc., 2023-OTA-532P (Sept. 19, 2023), the OTA held in a precedential opinion that the taxpayer failed to meet its burden of proof for substantiating its claimed R&D credit by providing the following supporting evidence, as described by the OTA: (1) the taxpayer’s audited financial statements, which contained a total line item for R&D expenses, but did not include the audit working papers or any document itemizing the expenses that… [read post]
8 Jan 2024, 2:02 am
EU On 21 December 2023, the CJEU issued judgement in the case of Krankenversicherung Nordrhein (C-667/21). [read post]
27 Dec 2023, 9:40 am
S&P Data LLC, 619 F.Supp.3d 445 (D. [read post]
26 Dec 2023, 9:06 am
Airbnb, Inc., 2023 WL 7166246 (D. [read post]
22 Dec 2023, 11:00 am
Solutions Law Press, Inc. invites you to receive future updates by registering on our Solutions Law Press, Inc. [read post]
21 Dec 2023, 4:00 am
C. [read post]
20 Dec 2023, 5:00 am
Monoclonal Antibodies Inc., 1985) protected large genus claims. [read post]
19 Dec 2023, 4:48 pm
On November 22, 2023, the Departments used their statutory authority (Internal Revenue Code Section 9816(c)(9), ERISA Section 716(c)(9), and PHS Act Section 2799A-1(c)(9)) to grant extensions in the following circumstances: Disputing parties may request additional time, beyond the current business day deadline, to respond to the certified IDR entity’s requests for additional information. [read post]
19 Dec 2023, 10:35 am
§ 223(d). [read post]
